Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
2.600
+0.060 (2.36%)
Apr 24, 2025, 9:32 AM EDT - Market open

Telomir Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
77123---
Enterprise Value
74122---
Last Close Price
2.544.12---
PB Ratio
117.57190.63---
P/TBV Ratio
117.56190.63---
Debt / Equity Ratio
0.140.140.18-0.62-0.86
Quick Ratio
1.861.860.000.00-
Current Ratio
1.941.940.330.05-
Return on Equity (ROE)
-810.18%-810.18%-1045.36%--
Return on Assets (ROA)
-250.96%-250.96%-102.18%--
Return on Capital (ROIC)
-318.60%-318.60%-132.78%--
Earnings Yield
-21.87%-13.49%---
Buyback Yield / Dilution
-8.18%-8.18%-1.77%--
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q